Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basir Tareen

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Journal of Endourology|September 16, 2010
What is the "true" incidence of active surveillance and brachytherapy candidates in men undergoing robot-assisted radical prostatectomy?James Bresee, Patricia Spuma, Michael Lipsky, et al.
International Journal of Medical Sciences|April 9, 2008
A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapyBasir Tareen, Jack L Summers, James M Jamison, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Journal of Endourology|September 16, 2010
What is the "true" incidence of active surveillance and brachytherapy candidates in men undergoing robot-assisted radical prostatectomy?James Bresee, Patricia Spuma, Michael Lipsky, et al.
International Journal of Medical Sciences|April 9, 2008
A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapyBasir Tareen, Jack L Summers, James M Jamison, et al.
Pageof 3